Rosuvastatin calcium vs Bempedoic acid/Ezetimibe
National NHS prescribing compared (Prescription Cost Analysis)
Rosuvastatin calcium was dispensed 10.3× as often as Bempedoic acid/Ezetimibe in May 2026 — 668,630 items versus 65,180 in England.
668,630items
Rosuvastatin calcium · May 2026
NHSBSA Prescription Cost Analysis
65,180items
Bempedoic acid/Ezetimibe · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Rosuvastatin calcium versus Bempedoic acid/Ezetimibe: national items dispensed by month
▬ Rosuvastatin calcium · ╌ Bempedoic acid/Ezetimibe
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Rosuvastatin calcium | Bempedoic acid/Ezetimibe |
|---|---|---|
| Items, May 2026 | 668,630 | 65,180 |
| Items, last 12 months | 7,597,329 | 647,866 |
| Net ingredient cost, May 2026 | £1,445,298 | £4,083,289 |
See the full profile for Rosuvastatin calcium or Bempedoic acid/Ezetimibe.